Syrykh, C., Pons-Brun, B., Russiñol, N., Playa-Albinyana, H., Baumann, T., Duran Ferrer, M., . . . Aymerich Gregorio, M. (2023). IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia.
Citación estilo ChicagoSyrykh, Charlotte, et al. IGLV3-21R110 Mutation Has Prognostic Value in Patients With Treatment-naive Chronic Lymphocytic Leukemia. 2023.
Cita MLASyrykh, Charlotte, et al. IGLV3-21R110 Mutation Has Prognostic Value in Patients With Treatment-naive Chronic Lymphocytic Leukemia. 2023.
Precaución: Estas citas no son 100% exactas.